Dolly Vance | Executive Vice President, Corporate Affairs and General Counsel |
Raul Rodriguez | Chief Executive Officer |
Eldon Mayer | Chief Commercial Officer |
Dean Schorno | Chief Financial Officer |
Ally Bratzel | Piper Jaffray |
Do Kim | BMO Capital Markets |
Tessa Romero | JPMorgan |
Kristen Kluska | Cantor Fitzgerald |
Greetings, and welcome to Rigel Pharmaceuticals' Financial Conference Call for the Third Quarter 2019. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel's Executive Vice President, Corporate Affairs and General Counsel. Thank you, Ms. Vance.